Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach
NCT ID: NCT01730560
Last Updated: 2025-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2010-11-29
2018-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the present study, the investigators developed a new approach to the compensatory visual field training based solely on a bottom-up mechanism. It does not require the patients' ability to voluntarily maintain attention oriented to the affected field, which may be difficult for brain-damaged patients. As previously reported in other pathological contexts (e.g. use of prism adaptation or sensory stimulation in neglect patients), bypassing voluntary and conscious implication of the patient can produce improvements by a more automatic process.
The investigators hypotheses are: 1) that a novel ramp-step search paradigm can be used by hemianopic patients to automatically improve targeted eye movements into their blind visual field; and 2) that this will lead to behavioural improvements on ecologically valid tests of visual search.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurofeedback-based Visual Restoration Therapy
NCT07237412
Functional Vision in TBI
NCT01214070
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NCT05085210
Motor Performance Improvement After Visual Rehabilitation
NCT06698172
Immersive Functional Virtual Reality in People With Acquired Brain Injury and Unilateral Spatial Neglect
NCT07017140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1:Treatment A
Treatment A (active) followed by treatment B (neutral)
Treatment A
The computer-based training task consists of a novel ramp-step search paradigm with a stimulus traversing the screen from left to right or right to left. Subjects are asked to pursue the stimulus (ramp phase) and then saccade to find its location when it suddenly jumps (step phase). The stimulus is an open spinning circle. At the end of each movement, the gap can be located at the top or at the bottom, and patients are asked to indicate this location by pushing the response button as quickly as possible.
The starting point will alternate between left and right. The training task includes 3 sessions with 100 movements each. Reaction Times and errors will be monitored online to ensure that the patient performs the task correctly.
Each treatment phase has the same pattern:
* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).
Arm 2: Treatment B
Treatment B (neutral) followed by treatment A (active)
Treatment B
Placebo treatment using the same computer-based training task, but including only the ramp phase.
Each treatment phase has the same pattern:
* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment A
The computer-based training task consists of a novel ramp-step search paradigm with a stimulus traversing the screen from left to right or right to left. Subjects are asked to pursue the stimulus (ramp phase) and then saccade to find its location when it suddenly jumps (step phase). The stimulus is an open spinning circle. At the end of each movement, the gap can be located at the top or at the bottom, and patients are asked to indicate this location by pushing the response button as quickly as possible.
The starting point will alternate between left and right. The training task includes 3 sessions with 100 movements each. Reaction Times and errors will be monitored online to ensure that the patient performs the task correctly.
Each treatment phase has the same pattern:
* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).
Treatment B
Placebo treatment using the same computer-based training task, but including only the ramp phase.
Each treatment phase has the same pattern:
* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stroke (ischemia or hemorrhage) documented by CTscan or MRI
* Traumatic brain injury (TBI) documented by CTscan or MRI
* Right or Left hemianopia defined by perimetry
* All subjects must be between the ages of 18-80
* Aetiology of visual field defect : Stroke (ischemia or hemorrhage)
* Delay post-stroke : at least 6 months
* Only one lesion on CTscan or MRI (performed in a maximal delay of 6 months)
* Corrected monocular visual acuity \> 5/10
* Possible understanding of experimental conditions
* Patient being able to be quiet and sit during at least 2 hours
* Having given written informed consent prior to any procedure related to the study
* Availability for the period of the study
* Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research
Exclusion Criteria
* Neurologic criteria : sever phasic disturbances , neurologic degenerative affection , non controlled seizure , severe handicap non compatible with prolonged sit position or concentration during 30 consecutive minutes
* No command of french language
* Non stabilized medical situation
* Females who are pregnant, nursing, or planning a pregnancy during the study period, or females of childbearing potential, not using a reliable means of contraception.
* Not under any administrative or legal supervision
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sophie Jacquin-Courtois, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Service de Médecine Physique et de Réadaptation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Médecine Physique et de Réadaptation,Hôpital Henry Gabrielle
Saint-Genis-Laval, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ong YH, Jacquin-Courtois S, Gorgoraptis N, Bays PM, Husain M, Leff AP. Eye-Search: A web-based therapy that improves visual search in hemianopia. Ann Clin Transl Neurol. 2015 Jan;2(1):74-8. doi: 10.1002/acn3.154. Epub 2014 Nov 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-A00702-37
Identifier Type: OTHER
Identifier Source: secondary_id
2010.615
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.